The Most Promising ASX BioTech Stock Review - Watchlist 2021 | Polynovo скачать в хорошем качестве

The Most Promising ASX BioTech Stock Review - Watchlist 2021 | Polynovo

In this video, I’m going to share a promising ASX BioTech Stock to watch in 2021 that I think will outperform the market in the medium to long term and also let you know what price I’m willing to buy them at. The stock that I analyse is Polynovo which specialises in skin wound repair for applications such as burns, hernia and breast reconstruction using their patented Novosorb BTM product. Of course, if you are not confident investing in medical stocks then the Healthcare Index XHJ might be more suitable. But with CSL dominating that index and itself not moving much in the past year, I'm more interested in Polynovo and seeing what it is able to achieve in the next 5 years. In fact, during my research for this video, I was excited enough to put in a small order and will be looking to average down my price and increasing my position over the next few months if the share price dips. Manage your shares correctly: Try Out Sharesight Here ▶︎ https://www.sharesight.com/thehealthy... Trade the ASX here: Selfwealth ▶︎ https://secure.selfwealth.com.au/Regi... Trade the US Stock Market here: Stake (Get a free stock!) ▶︎ https://hellostake.com/referral-progr... ⏱️TIMESTAMPS 0:00 Intro 1:04 Polynovo Introduction 2:05 Financial Analysis 4:11 Future Pipeline and Prospects 5:33 Future Broker Consensus 6:11 Risks to watch for 7:02 Price Target 7:30 Closing Free Range by Mona Wonderlick   / monawonderlick​   Creative Commons — Attribution 3.0 Unported — CC BY 3.0 Free Download / Stream: http://bit.ly/-free-range​ Music promoted by Audio Library    • Free Range – Mona Wonderlick (No Copyright...   Disclaimer The information on this video is for general information purposes only. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser.